What is the recommended dose of albuterol (bronchodilator) for an 11-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albuterol Dosing for an 11-Month-Old

For an 11-month-old infant with bronchospasm, administer 0.63 mg/3 mL of albuterol nebulizer solution every 4-6 hours as needed, or alternatively 1-2 puffs (90 mcg per puff) via metered-dose inhaler with spacer and face mask every 4-6 hours. 1

Standard Maintenance Dosing

Nebulizer Solution (Preferred for This Age)

  • Dose: 0.63 mg/3 mL administered every 4-6 hours as needed for bronchospasm 1
  • This is the American Academy of Pediatrics-recommended dose for all children under 5 years of age 1
  • Use oxygen as the preferred gas source for nebulization at 6-8 L/min flow rate 1
  • The treatment should be delivered over approximately 5-15 minutes 2

Metered-Dose Inhaler Alternative

  • Dose: 1-2 puffs (90 mcg per puff) every 4-6 hours as needed 1
  • Critical requirement: Must use a spacer/valved holding chamber with face mask for children under 4 years, as drug delivery is dramatically reduced without it 1
  • Puffs can be taken in 10-15 second intervals 1

Acute Exacerbation Dosing

For Moderate to Severe Bronchospasm

  • Initial treatment: 0.63 mg every 20 minutes for 3 doses, then every 1-4 hours as needed 1
  • Weight-based calculation (0.075 mg/kg) at 11 months may yield doses below the minimum effective threshold 1
  • Always use the minimum dose of 1.25 mg if weight-based calculation yields a lower number for acute exacerbations 1
  • However, for routine maintenance in infants under 15 kg, the 0.63 mg dose is appropriate 1, 2

MDI for Acute Symptoms

  • 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 1
  • Again, spacer with face mask is mandatory 1

Important Clinical Considerations

Severe Status Asthmaticus

  • For life-threatening exacerbations requiring continuous nebulization: 0.5 mg/kg per hour up to 10-15 mg/hour 1
  • Must be diluted in 25-30 mL saline for 1 hour of nebulization 1

Adjunctive Therapy for Severe Cases

  • Consider adding ipratropium bromide 0.25 mg to albuterol nebulization every 20 minutes for the first 3 doses in severe exacerbations 1
  • For very young children, half doses (approximately 100-125 mcg) of ipratropium can be used 3
  • The combination can be mixed in the same nebulizer solution 1

Safety Monitoring

Watch for Adverse Effects

  • Monitor for tachycardia, skeletal muscle tremor, hypokalemia, hyperglycemia, and headache 1
  • Repeat administration and adjust dose until desired clinical effect is achieved, unless symptomatic tachycardia develops 1

Warning Signs

  • Increasing use or lack of expected effect indicates diminishing control and requires immediate medical reassessment 1
  • This is often a sign of seriously worsening respiratory disease requiring therapy escalation 2

Critical Pitfalls to Avoid

  1. Never use oral albuterol formulations in acute settings—they have slower onset, reduced effectiveness, and increased systemic side effects 4

  2. Failure to use spacer with face mask in infants dramatically reduces drug delivery—this is non-negotiable for MDI administration 1

  3. Do not underdose in acute exacerbations—while 0.63 mg is appropriate for maintenance, acute situations may require 1.25 mg minimum 1

  4. Supplemental oxygen may be needed when using compressed air-driven nebulizers 1

References

Guideline

Albuterol Dosing Guidelines for Pediatric Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bromuro de Ipratropio Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Bronchospasm in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.